Based on the key indicators related to Biofrontera Warrants' liquidity, profitability, solvency, and operating efficiency, Biofrontera Warrants is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At this time, Biofrontera Warrants' Property Plant And Equipment Gross is fairly stable compared to the past year. Total Current Assets is likely to climb to about 34.2 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 15.2 M in 2025. Key indicators impacting Biofrontera Warrants' financial strength include:
Investors should never underestimate Biofrontera Warrants' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Biofrontera Warrants' cash flow, debt, and profitability to make informed and accurate decisions about investing in Biofrontera Warrants.
Net Income
(19.02 Million)
Biofrontera
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change To Inventory
Investments
Change In Cash
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Non Currrent Assets Other
Cash And Short Term Investments
Net Receivables
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Other Stockholder Equity
Total Liab
Net Invested Capital
Property Plant And Equipment Gross
Total Current Assets
Capital Stock
Non Current Liabilities Other
Net Working Capital
Intangible Assets
Common Stock
Current Deferred Revenue
Short Term Investments
Capital Lease Obligations
Short Term Debt
Tax Provision
Net Interest Income
Interest Income
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling And Marketing Expenses
Probability Of Bankruptcy
Understanding current and past Biofrontera Warrants Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biofrontera Warrants' financial statements are interrelated, with each one affecting the others. For example, an increase in Biofrontera Warrants' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Biofrontera Warrants' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biofrontera Warrants. Check Biofrontera Warrants' Beneish M Score to see the likelihood of Biofrontera Warrants' management manipulating its earnings.
Biofrontera Warrants Key Income Statement Accounts
The reason investors look at the income statement is to determine what Biofrontera Warrants' earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Biofrontera Warrants's current stock value. Our valuation model uses many indicators to compare Biofrontera Warrants value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biofrontera Warrants competition to find correlations between indicators driving Biofrontera Warrants's intrinsic value. More Info.
Biofrontera Warrants is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Biofrontera Warrants' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biofrontera Warrants by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Biofrontera Warrants Market Pulse
Quote
0.1
Change(%)
16.67
Change
0.02
Open
0.12
Low
0.099
High
0.15
Volume
0
Exchange
NASDAQ
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Biofrontera Warrants is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Biofrontera has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Biofrontera Warrants' financials are consistent with your investment objective using the following steps:
Review Biofrontera Warrants' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
Study the cash flow inflows and outflows to understand Biofrontera Warrants' liquidity and solvency.
Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
Compare Biofrontera Warrants' financials to those of its peers to see how it stacks up and identify any potential red flags.
Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Biofrontera Warrants' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.
Today, most investors in Biofrontera Warrants Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biofrontera Warrants' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Biofrontera Warrants growth as a starting point in their analysis.
Biofrontera Warrants February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biofrontera Warrants help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biofrontera Warrants. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biofrontera Warrants based on widely used predictive technical indicators. In general, we focus on analyzing Biofrontera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biofrontera Warrants's daily price indicators and compare them against related drivers.
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.